PureTech News

Press Releases
ALL >
Press Release - 2026-10-19
Gallop Oncology – LYT-200
PureTech Announces Presentation of Phase 1b Results for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) and Acute Myeloid Leukemia (AML) at ESMO 2026
Continue
Press Release - 2026-10-09
Seaport
PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress
Continue
Press Release - 2026-10-07
Seaport
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo™ in Patients with Generalized Anxiety Disorder and Sleep Disturbance
Continue
Publications
ALL >
Publications 2026-04-02
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Full Article
Publications 2026-03-25
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans
Full Article
Publications 2025-05-08
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study
Full Article

@PureTechH